More study needed before combination therapies for AMD accepted

Baltimore?Photodynamic therapy (PDT) has been the mainstay of treatment for choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD) until recently when combination therapies (PDT and anti-vascular endothelial growth factor [VEGF]) agents started to be explored.

Related Videos
View All
Related Content

Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

4D Molecular Therapeutics announces FDA clearance of IND application for 4D-150 genetic medicine for the treatment of DME

February 3rd 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Novel gene therapy shows promise for treating multiple eye diseases

February 3rd 2023

International Keratoconus Academy continues to provide cutting-edge education

February 2nd 2023

Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

4D Molecular Therapeutics announces FDA clearance of IND application for 4D-150 genetic medicine for the treatment of DME

February 3rd 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Novel gene therapy shows promise for treating multiple eye diseases

February 3rd 2023

International Keratoconus Academy continues to provide cutting-edge education

February 2nd 2023

Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

4D Molecular Therapeutics announces FDA clearance of IND application for 4D-150 genetic medicine for the treatment of DME

February 3rd 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

Novel gene therapy shows promise for treating multiple eye diseases

February 3rd 2023

International Keratoconus Academy continues to provide cutting-edge education

February 2nd 2023
Advertise
Privacy
Editorial
Terms and Conditions
Contact Us
Do Not Sell My Personal Information
Job Board
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.